0.5241
Clearside Biomedical Inc Borsa (CLSD) Ultime notizie
What drives Clearside Biomedical Inc. stock priceFree Real-Time Stock Data - PrintWeekIndia
What analysts say about Clearside Biomedical Inc. stockBreakthrough stock performance - PrintWeekIndia
Why Clearside Biomedical Inc. stock attracts strong analyst attentionFree Stock Market Analysis Courses - Newser
Clearside Biomedical Receives Canadian Approval for XIPERE® to Treat Uveitic Macular Edema via Suprachoroidal Delivery - MSN
Clearside Biomedical Announces Approval of XIPERE® - GlobeNewswire
Is Clearside Biomedical Inc. a good long term investmentExceptional portfolio growth - Autocar Professional
Clearside Biomedical stock soars after Health Canada approves XIPERE - Investing.com Australia
Clearside Biomedical stock soars after Health Canada approves XIPERE By Investing.com - Investing.com UK
Health Canada approves Clearside’s XIPERE for uveitic macular edema By Investing.com - Investing.com Nigeria
Breakthrough Eye Treatment XIPERE Secures Major Health Canada Approval for Macular Edema - Stock Titan
Clearside Biomedical Inc. Stock Analysis and ForecastFree Market Volatility Navigation Tips - jammulinksnews.com
Clearside exploring options to advance suprachoroidal delivery platform - Eyes On Eyecare
Clearside Biomedical announces plan to explore strategic alternatives to advance its proprietary suprachoroidal space (SCS) delivery platform and promising ophthalmology pipeline - Eyes On Eyecare
Analysts Set Clearside Biomedical, Inc. (NASDAQ:CLSD) Target Price at $4.20 - Defense World
Uncovering the Potential of Clearside Biomedical Inc (CLSD) Stock - investchronicle.com
Clearside Biomedical (NASDAQ:CLSD) Downgraded by Stifel Nicolaus to "Hold" - MarketBeat
Chardan Capital Downgrades Clearside Biomedical (NASDAQ:CLSD) to Neutral - Defense World
What institutions are buying Clearside Biomedical Inc. stock nowFree Stock Trading Signals - beatles.ru
Published on: 2025-07-18 21:44:13 - Newser
Clearside Biomedical downgraded to Neutral from Buy at H.C. Wainwright - TipRanks
Health Care Stocks Stumble As Sector Faces Fresh Setbacks - Finimize
Deal Dispatch: Del Taco Tanks, Tylenol Maker Aches For Change, Joyebells Burns The Pie - Benzinga
Published on: 2025-07-18 22:42:56 - jammulinksnews.com
This Verint Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday - Benzinga
A Quick Look at Today's Ratings for Clearside Biomedical(CLSD.US), With a Forecast Between $0.84 to $3 - 富途牛牛
Clearside Biomedical downgraded to Neutral from Buy at Chardan - TipRanks
This Elevance Health Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Friday - Benzinga
CLSD: Downgraded to Neutral by HC Wainwright & Co. | CLSD Stock News - GuruFocus
Why Clearside Biomedical Inc. stock is on top investor watchlistsHigh Return Stock Alerts - Newser
Chardan Capital downgrades Clearside Biomedical stock rating to Neutral By Investing.com - Investing.com Canada
Chardan Capital downgrades Clearside Biomedical stock rating to Neutral - Investing.com
Stifel downgrades Clearside Biomedical stock to Hold on cash concerns By Investing.com - Investing.com Nigeria
Stifel downgrades Clearside Biomedical stock to Hold on cash concerns - Investing.com Australia
Clearside Biomedical Downgraded to Hold Amid Strategic and Financial Uncertainties - TipRanks
Clearside Biomedical downgraded to Hold from Buy at Stifel - TipRanks
Clearside Biomedical Announces Plan to Explore Strategic - GlobeNewswire
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):